semaglutide hammond Weight Loss Clinic Indiana Compounded Semaglutide / Glycine /

This surge coincided with Zepbounds approval for OSA, marking the largest observed difference in uptake between patients with and without a comorbidity

Evidence-based comparison of ribupatide (dual GLP-1/GIP agonist) and tirzepatide (dual GIP/GLP-1 agonist), including injectable, oral, and Phase 3 KaiNETIC program data.

### Competing Interest Statement Dr

Curious about getting Wegovy from your OBGYN

Interesting paper by Viral NShah, Tadej Battelino, Moshe Phillip and Rich Bergenstal

The evidence, SELECT, n=17,604 First MACE: HR 0.80, 95% CI 0.72 to 0.90 Non-fatal MI: HR 0.72, 95% CI 0.61 to 0.85 Coronary revascularisation: HR 0.77, 95% CI 0.68 to 0.87 All-cause : HR 0.81, 95% CI 0.71 to 0.93 (Lincoff et al, NEJM 2023) Benefit appeared early, before substantial weight loss, supporting a mechanism partly independent of weight reduction